Home Nav
Nextech Invest Logo

Lukas Rindlisbacher

Alfred Scheidegger

Lukas Rindlisbacher completed an B.Sc. specializing in molecular cell biology in 2016, and a Master of Molecular Health Science in 2018, both from ETH Zurich, Switzerland. During his master thesis in the lab of Prof. Neri, he gained scientific experience in biology with specialization on bispecific antibodies.


J.P. Morgan 37th Annual Healthcare Conference

07.01. – 10.01.2019

San Francisco, CA, USA

  • 26.12.2018

    Tracon Pharmaceuticals Presents Positive Top-line Clinical...

  • 21.12.2018

    Tracon Pharmaceuticals Announces Top-line Data from...

  • 07.12.2018

    Arvinas Presents Preclinical Data on Protein Degrader,...


Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.


* Compulsory fields


Newsletter Registration

Your eMail have been successfully registered.